Skip to main content
Top
Published in: Abdominal Radiology 7/2015

01-10-2015

Intrahepatic cholangiocarcinomas mimicking other lesions

Authors: Sharon Z. Adam, Sudharshan Parthasarathy, Frank H. Miller

Published in: Abdominal Radiology | Issue 7/2015

Login to get access

Abstract

Background

While the typical features of large cholangiocarcinomas have been described extensively and are known to radiologists, atypical cholangiocarcinomas are not as well known and radiologists should be more aware of their features. Due to the increasing numbers of cross-sectional imaging studies performed for various reasons, cholangiocarcinomas may be more frequently detected incidentally when small, before they become symptomatic, and might be mistaken for other liver lesions. We studied the appearance of misdiagnosed cholangiocarcinomas.

Materials and methods

This is a HIPAA-compliant, IRB-approved retrospective study. Our institutional database and teaching files were searched for cases of cholangiocarcinomas diagnosed between 2004 and 2014 that were initially misdiagnosed or considered indeterminate lesions on MRI or CT. Clinical data and radiological findings were collected. History of malignancy and risk factors for cholangiocarcinoma were recorded. The initial reported diagnosis and time to the correct diagnosis were noted, and the lesions were evaluated for size, enhancement, T1/T2 signal, diffusion restriction, ADC value, capsular retraction, biliary dilatation and the presence of satellite nodules.

Results

Nine examples of cholangiocarcinoma that met our inclusion criteria were identified: seven men and two women. All were small, with a mean size of 2.2 cm upon initial diagnosis. All showed a hypervascular pattern of enhancement without washout. Imaging features that are described in the literature as typical for cholangiocarcinomas, such as capsular retraction, satellite nodules, and peripheral biliary dilatation, were not seen.

Conclusion

Cholangiocarcinomas can be misdiagnosed when they are small and hypervascular. This atypical hypervascular appearance is rare, and may mimic benign liver lesions and other malignant lesions, especially when small. Awareness of the confounding imaging features of these tumors should lead to a more meticulous evaluation of small hypervascular lesions, and may minimize the risk of misdiagnosing early-stage cholangiocarcinomas.
Literature
1.
go back to reference Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98(12):873–875. doi:10.1093/jnci/djj234 CrossRefPubMed Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98(12):873–875. doi:10.​1093/​jnci/​djj234 CrossRefPubMed
7.
go back to reference Hamrick-Turner J, Abbitt PL, Ros PR (1992) Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 158(1):77–79CrossRefPubMed Hamrick-Turner J, Abbitt PL, Ros PR (1992) Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 158(1):77–79CrossRefPubMed
8.
go back to reference Vilgrain V, Van Beers BE, Flejou JF (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21(1):59–65CrossRefPubMed Vilgrain V, Van Beers BE, Flejou JF (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21(1):59–65CrossRefPubMed
17.
19.
go back to reference Park HJ, Kim YK, Park MJ, Lee WJ (2013) Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging 38(4):793–801. doi:10.1007/s00261-012-9943-x CrossRefPubMed Park HJ, Kim YK, Park MJ, Lee WJ (2013) Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging 38(4):793–801. doi:10.​1007/​s00261-012-9943-x CrossRefPubMed
25.
go back to reference Park MJ, Kim YK, Park HJ, Hwang J, Lee WJ (2013) Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma. J Comput Assist Tomogr 37(6):872–881. doi:10.1097/RCT.0b013e31829d44c1 CrossRefPubMed Park MJ, Kim YK, Park HJ, Hwang J, Lee WJ (2013) Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma. J Comput Assist Tomogr 37(6):872–881. doi:10.​1097/​RCT.​0b013e31829d44c1​ CrossRefPubMed
26.
go back to reference Kim SH, Lee CH, Kim BH, et al. (2012) Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 36(6):704–709. doi:10.1097/RCT.0b013e3182706562 CrossRefPubMed Kim SH, Lee CH, Kim BH, et al. (2012) Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 36(6):704–709. doi:10.​1097/​RCT.​0b013e3182706562​ CrossRefPubMed
27.
28.
go back to reference Yoshida Y, Imai Y, Murakami T, et al. (1999) Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 24(1):66–68CrossRefPubMed Yoshida Y, Imai Y, Murakami T, et al. (1999) Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 24(1):66–68CrossRefPubMed
29.
go back to reference Nanashima A, Abo T, Murakami G, et al. (2013) Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics. Abdom Imaging 38(4):785–792. doi:10.1007/s00261-012-9974-3 CrossRefPubMed Nanashima A, Abo T, Murakami G, et al. (2013) Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics. Abdom Imaging 38(4):785–792. doi:10.​1007/​s00261-012-9974-3 CrossRefPubMed
30.
go back to reference Ariizumi S, Kotera Y, Takahashi Y, et al. (2011) Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes. J Surg Oncol 104(2):130–139. doi:10.1002/jso.21917 CrossRefPubMed Ariizumi S, Kotera Y, Takahashi Y, et al. (2011) Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes. J Surg Oncol 104(2):130–139. doi:10.​1002/​jso.​21917 CrossRefPubMed
33.
go back to reference Nam SJ, Park KY, Yu JS, et al. (2012) Hepatic cavernous hemangiomas: relationship between speed of intratumoral enhancement during dynamic MRI and apparent diffusion coefficient on diffusion-weighted imaging. Korean J Radiol: Off J Korean Radiol Soc 13(6):728–735. doi:10.3348/kjr.2012.13.6.728 CrossRef Nam SJ, Park KY, Yu JS, et al. (2012) Hepatic cavernous hemangiomas: relationship between speed of intratumoral enhancement during dynamic MRI and apparent diffusion coefficient on diffusion-weighted imaging. Korean J Radiol: Off J Korean Radiol Soc 13(6):728–735. doi:10.​3348/​kjr.​2012.​13.​6.​728 CrossRef
36.
Metadata
Title
Intrahepatic cholangiocarcinomas mimicking other lesions
Authors
Sharon Z. Adam
Sudharshan Parthasarathy
Frank H. Miller
Publication date
01-10-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0480-2

Other articles of this Issue 7/2015

Abdominal Radiology 7/2015 Go to the issue

Classics in Abdominal Imaging

Coffee bean sign

Classics in Abdominal Imaging

The “staghorn” calculus

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.